Heterostructure nanozyme-synergistically modulated electrochemiluminescence/photoelectrochemical sensing platform for detection of Alzheimer's disease biomarkers in plasma samples
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.119004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Qiumei Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, 221116, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Biosensing Techniques, Peptide Fragments. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
In this work, a PtPd/CeO2 heterostructure nanozyme-synergistically modulated ternary ZnS/CdS/Bi2Se3 electrochemiluminescence/photoelectrochemical (ECL/PEC) aptasensor was designed for simultaneous detection of amyloid-β peptides (Aβ1-40 and Aβ1-42), as the key plasma biomarkers of Alzheimer's disease (AD). Benefiting from the bimetallic alloy effect and the support-active component synergy, PtPd/CeO2 heterostructure efficiently accelerated interfacial electron transfer, leading to both an improved catalytic reaction kinetic rate and enhanced adsorption and activation of reactants. Ternary ZnS/CdS/Bi2Se3 achieved photocurrent self-enhancement via synergistic bandgap excitation and multi-interface charge transfer effects among its components, thereby significantly boosting the response signals of both ECL and PEC. Through the integration of aptamer-mediated specific target recognition and toehold-triggered strand displacement reaction (TSDR)-based signal amplification, this aptasensor realized the simultaneous detection of Aβ1-42 and Aβ1-40. Notably, practical validation of the aptasensor for Aβ1-42/Aβ1-40 ratio detection in actual plasma specimens demonstrated the feasibility of minimally invasive liquid biopsy with high patient compliance and great potential for large-scale screening and early diagnosis of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, 221116, China.
- Department of Neurology, Xuzhou Central Hospital, Xuzhou, 221009, China.
- Department of Engineering Science and Mechanics, Pennsylvania State University, University Park, State College, PA, 16802, USA.
- School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, 221116, China. Electronic address: wangpo@jsnu.edu.cn.
- Department of Neurology, Xuzhou Central Hospital, Xuzhou, 221009, China. Electronic address: cgfxdd@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Feng, Q., Song, Y., Pan, Z., Liu, W., Xu, H., Wang, L., Cheng, H., Wang, P., & Chen, G. (2026). Heterostructure nanozyme-synergistically modulated electrochemiluminescence/photoelectrochemical sensing platform for detection of Alzheimer's disease biomarkers in plasma samples. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119004
Vancouver
Feng Q, Song Y, Pan Z, Liu W, Xu H, Wang L, et al. Heterostructure nanozyme-synergistically modulated electrochemiluminescence/photoelectrochemical sensing platform for detection of Alzheimer's disease biomarkers in plasma samples. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.119004
BibTeX
@article{Feng2026,
author = {Feng, Qiumei and Song, Yao and Pan, Zhouqi and Liu, Weiwei and Xu, Hui and Wang, Lei and Cheng, Huanyu and Wang, Po and Chen, Guofang},
title = {Heterostructure nanozyme-synergistically modulated electrochemiluminescence/photoelectrochemical sensing platform for detection of Alzheimer's disease biomarkers in plasma samples},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.119004}
}
EUVIMED